Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Outlook strong for home services with pros confident in 2025 growth
-
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
-
Your Dream Stay, Now on Sale: IHG Hotels & Resorts Cyber Sale Deals Are Here for a Limited Time
-
Southeastern Grocers feeds the spirit of Thanksgiving by donating 7,000 turkeys to neighbors experiencing hunger
-
ZIM Reports Financial Results for the Third Quarter of 2024; Raises Full Year 2024 Guidance
-
Melt Pharmaceuticals Reports Positive Phase 3 Topline Efficacy Results for MELT-300, Its Lead Product Candidate for Opioid-Free, Sublingual Procedural Sedation in Patients Undergoing Cataract Surgery
-
Northern Trust Launches Enhanced Collateral Management Solution Delivered in Collaboration with CloudMargin
-
POSaBIT Announces Full Integration of Metrc Connect
-
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
-
Missouri American Water Provides Tips for Identifying Scammers on Utility Scam Awareness Day
-
Colossal Foundation Donates $1.5M USD to the University of Melbourne to Support Avian Conservation
-
NAI Group to Open New Manufacturing Facility In Malaysia
-
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
-
Justin Drake, PhD, Announced as Recipient of RETpositive/LUNGevity Research Award
-
‘It’s Cloud On’: AWS and Bellevue University Team Up to Connect More Learners to Cloud Careers
-
GMS Launches Generative Response Ads, Pioneers Real-Time Conversations Within Ads with PH firm AdSpark
-
Amy Cummings, MD, PhD, and Romel Somwar, PhD, Honored as Recipients of the Hamoui Foundation/LUNGevity Clinical Research Award
-
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
-
Veritone Unveils Data Refinery to Power Next-Generation AI Technology
-
Kinematics Announces Definitive Agreement to Acquire Controller Leader P4Q
-
Remix Therapeutics to Present Preclinical Data Demonstrating Anti-Leukemic Activity of REM-422 in AML at the 66th American Society of Hematology Annual Meeting and Exposition (ASH)
-
Denodo Platform 9.1 Brings New Advanced AI Capabilities and Enhanced Data Lakehouse Performance
-
Addressable TV Advertising Grows for Third Year in a Row as 53% of Advertisers Call It a Must-Buy
-
Xtract One Announces Fiscal 2025 First Quarter Conference Call
-
Seaport Therapeutics Adds Sandi Peterson to its Board of Directors
-
Valora Therapeutics Raises $30 Million Seed Financing from Top Investors to Transform Immunotherapy with a Novel Glyco-immune Checkpoint Platform
-
Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference
-
Adastra’s Smart Retail Insights Solution Passes the AWS Foundational Technical Review
-
Sol-Gel Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement
-
Update on Clinical Milestone - CytoMed Therapeutics Announces First Patient Dosed in its First-in-Human Phase I Clinical Trial of Allogeneic CAR-Gamma Delta T Cell Therapy in Patients with Advanced So
-
CONNEXA RECEIVES NASDAQ APPROVAL TO ACQUIRE YUANYU ENTERPRISE MANAGEMENT
-
NIP Group to Report Financial Results for the First Half of 2024 on November 25, 2024
-
RYVYL Amends MOU to Adjust Timing of First Tranche Payment to Investor to Retire 8% Senior Convertible Note and Series B Convertible Preferred Stock
-
Algorhythm Holdings Reports Third Quarter 2024 Results
-
Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery
-
PyroGenesis Anticipates Positive Economic Impact from Incoming Administration in the U.S.
-
Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
-
Solaris Announces Final Steps to Complete Emigration by Year-End, Including Management and Board Changes; Growth-Oriented Spin-out Anticipated in 2025
-
C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors
-
Global-e Reports Third Quarter 2024 Results
-
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or
-
OTC Markets Group Announces Launch of MOON ATS, A New Overnight Trading Platform for National Market System (NMS) Securities
-
FactSet Schedules First Quarter 2025 Earnings Call
-
Dataprana Confirms Intent to Co-Develop Its First AI Data Center in Texas
-
Worldline - Monthly information relating to the total number of voting rights and shares making up the share capital
-
OXB to host a free webinar on accelerating development of viral vectors through automated manufacturing and analytical development
-
Avextra Portugal Unveils Advanced Breeding Program to Develop Proprietary THC and CBD Cultivars, Establishing a Key IP Pillar
-
Endeavour Silver Corp. Announces US$73 Million Bought Deal Financing
-
Garmin's revolutionary Runway Occupancy Awareness technology honored with prestigious Laureate Award
-
Garmin inReach Messenger Plus wins 2025 CES Best of Innovation award

